From Israel Hayom: “Regarding the safety issue of the treatment, petitioners claim that the use of the word ‘rare’ to describe the risk of brain damage and loss of memory due to ECT is misleading, since without a standard and universal protocol for supervision and performance, and without routine assessment and monitoring of every patient, there will be never be a real clear indication of the prevalence of brain damage.
This is in addition to the fact that, to date, researchers have never followed patients for more than six months from the end of treatment to detect or identify cognitive impairment”. One of the key requirements of this petition is to conduct comprehensive pre-treatment and subsequent testing to detect adverse events ahead of time and prevent a condition of serious or irreversible damages.”